
10x Genomics, Inc.
TXGNasdaqCIK 1770787TechnologyFiscal year ends Dec 31
Reports and events: 112 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-02-1616:48 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001770787-23-000012 |
| 2023-02-1516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770787-23-000006 |
| 2022-11-0320:43 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001770787-22-000057 |
| 2022-11-0216:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770787-22-000053 |
| 2022-08-0919:30 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001770787-22-000049 |
| 2022-08-0816:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770787-22-000047 |
| 2022-08-0317:09 ET | 8-K | 2.05 Exit or disposal costs | 0001770787-22-000040 |
| 2022-07-1416:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001770787-22-000036 |
| 2022-06-1716:05 ET | 8-K | 5.07 Shareholder vote results | 0001770787-22-000032 |
| 2022-05-0516:06 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001770787-22-000029 |
| 2022-05-0416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770787-22-000026 |
| 2022-04-2916:07 ET | DEF 14A | Proxy statementPeriod 2022-06-15 | 0001770787-22-000022 |
| 2022-02-1816:06 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001770787-22-000015 |
| 2022-02-1616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770787-22-000004 |
| 2021-11-0516:06 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001770787-21-000054 |
| 2021-11-0316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770787-21-000048 |
| 2021-08-0616:05 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001770787-21-000044 |
| 2021-08-0416:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770787-21-000041 |
| 2021-07-3017:04 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-21-231651 |
| 2021-07-3017:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-21-231635 |
| 2021-07-2706:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001770787-21-000039 |
| 2021-06-1517:01 ET | 8-K | 1.01 Entry into a material agreement; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001770787-21-000036 |
| 2021-06-0218:47 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001770787-21-000033 |
| 2021-05-0716:07 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001770787-21-000031 |
| 2021-05-0516:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770787-21-000028 |
| 2021-04-2316:10 ET | DEF 14A | Proxy statementPeriod 2021-06-11 | 0001770787-21-000024 |
| 2021-04-2316:07 ET | 10-K/A | Annual report, amendedPeriod 2020-12-31 | 0001770787-21-000023 |
| 2021-02-2616:10 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001770787-21-000009 |
| 2021-02-1716:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770787-21-000005 |
| 2020-11-1216:15 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001770787-20-000009 |
| 2020-11-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001770787-20-000006 |
| 2020-10-1309:21 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-20-268056 |
| 2020-10-0516:17 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001770787-20-000003 |
| 2020-09-0816:11 ET | S-1 | Registration statement | 0001193125-20-240997 |
| 2020-08-1216:07 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001628280-20-012520 |
| 2020-08-1116:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-20-012434 |
| 2020-06-1816:57 ET | 8-K | 1.02 Termination of a material agreement; 5.07 Shareholder vote results | 0001193125-20-172579 |
| 2020-05-1216:03 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001193125-20-140382 |
| 2020-05-1116:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-139010 |
| 2020-04-2416:02 ET | DEF 14A | Proxy statementPeriod 2020-06-15 | 0001193125-20-119032 |
| 2020-04-0916:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-102557 |
| 2020-04-0116:07 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-20-094606 |
| 2020-03-2616:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-20-087045 |
| 2020-02-2716:07 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001193125-20-052640 |
| 2020-02-1816:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-040295 |
| 2020-02-1421:06 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-20-036029 |
| 2019-12-1916:01 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-19-319075 |
| 2019-12-1217:04 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-19-312837 |
| 2019-12-1116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-19-311471 |
| 2019-12-1119:25 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-19-310457 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 22:35 ET. Listed shows no prices and gives no investment advice.